
Norgine Strengthens Rare Disease Portfolio With Acquisition Of Theravia
(MENAFN- PR Newswire) Acquisition of Theravia from Mérieux Equity Partners represents meaningful step forward in Norgine's strategy for sustainable growth, adding a complementary portfolio of rare disease medicines Transaction further establishes …